Live from the NIH registry
Studies recruiting near Louisville right now
Top 25 of 559 recruiting studies, sorted by proximity — each links to its official registry page
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Jewish Hospital — Louisville, Kentucky (8.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Myelodysplastic Syndrome, Acute Myeloid Leukemia
Phase 1
Interventional 178 participants sought
Norton Hospitals, Inc — Louisville, Kentucky (8.6 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
The James Graham Brown Cancer Center at University of Louisville — Louisville, Kentucky (8.6 mi)
· Sponsor: NRG Oncology
Treatment of Moderate to Severe Refractory Crohn's Disease
Crohns Disease
Phase 1, Phase 2
Interventional 39 participants sought
University of Louisville — Louisville, Kentucky (8.6 mi)
· Sponsor: Tr1X, Inc.
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Baptist Health - Louisville — Louisville, Kentucky (8.6 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
University of Louisville Hospital — Louisville, Kentucky (8.6 mi)
· Sponsor: Hoffmann-La Roche
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Norton Women's and Children's Hospital-Norton Cancer Institute - St. Matthews ( Site 0185) — Louisville, Kentucky (8.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Louisville, KY — Louisville, Kentucky (8.6 mi)
· Sponsor: Mediar Therapeutics
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Jewish Hospital — Louisville, Kentucky (8.6 mi)
· Sponsor: SWOG Cancer Research Network
Complex Adult Deformity Surgery (CADS)
Adult Spinal Deformity, Scoliosis
N/A
Observational 1,500 participants sought
Norton Leatherman Spine Center — Louisville, Kentucky (8.6 mi)
· Sponsor: International Spine Study Group Foundation
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Norton Children's Hospital — Louisville, Kentucky (8.6 mi)
· Sponsor: Children's Oncology Group
Supporting Resilience Among Re-entered Seniors
Chronic Disease
N/A
Interventional 8 participants sought
New Legacy Reentry — Louisville, Kentucky (8.6 mi)
· Sponsor: University of Louisville
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Louisville, Kentucky (8.6 mi)
· Sponsor: TG Therapeutics, Inc.
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
University of Louisville Physicians — Louisville, Kentucky (8.6 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Gastroenterology Health Partners — Louisville, Kentucky (8.6 mi)
· Sponsor: Eli Lilly and Company
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Neuroblastoma
Phase 2
Interventional 500 participants sought
Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine — Louisville, Kentucky (8.6 mi)
· Sponsor: Giselle Sholler
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
James Graham Brown Cancer Center ( Site 0058) — Louisville, Kentucky (8.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair
Hand Transplantation, Peripheral Nerve Injuries
N/A
Interventional 180 participants sought
Christine Kleinert Institute for Hand & Microsurgery — Louisville, Kentucky (8.6 mi)
· Sponsor: University of Missouri-Columbia
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Metastatic Breast Cancer
Phase 3
Interventional 600 participants sought
Norton Cancer Institute — Louisville, Kentucky (8.6 mi)
· Sponsor: LeonaBio
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10086, Louisville, Kentucky — Louisville, Kentucky (8.6 mi)
· Sponsor: Colorado Prevention Center
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Phase 4
Interventional 300 participants sought
Lake Cumberland Rheumatology — New Albany, Indiana (12.6 mi)
· Sponsor: Amgen
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Louisville, Kentucky (8.6 mi)
· Sponsor: AstraZeneca
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50586 — Louisville, Kentucky (8.6 mi)
· Sponsor: UCB Biopharma SRL
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
CommonSpirit Saint Joseph Hospital - Bardstown — Bardstown, Kentucky (26.6 mi)
· Sponsor: NRG Oncology
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Chronic Inducible Urticaria, Cold Urticaria
Phase 3
Interventional 240 participants sought
Advanced ENT and Allergy, PLLC — Louisville, Kentucky (8.6 mi)
· Sponsor: Celldex Therapeutics